Technology Trends in Biodegradable Polymers: Evidence from Patent Analysis

The public and governmental awareness regarding more sustainable products have gained significant momentum in the last decade and are directing the future research of the next generation of materials and processes. In such a setting, biodegradable polymers are regarded as one of the technologies driving the innovation and current market growth because they provide an additional end of life option. Tracing the evolving trends of these emerging technologies will help researchers, investors, and policy makers to better evaluate the opportunities of the technology as well as to understand the technology's changing characteristics. Therefore, within this study, we perform bibliographic analyses based on patent information to delineate the current research landscape and to anticipate the future development trends by focusing on the cases of poly(lactic acid) (PLA), poly(hydroxyalkanoates) (PHAs), polycaprolactone (PCL), poly(butylene succinate) (PBS), and poly(butylene adipate-co-terephthalate) (PBAT). The following findings were made: First, PLA gets the highest attention from both academia and industry. Second, the overall international presence of biodegradable polymer patents is high, especially in the field of PHAs. Third, technology maturity and technology strength show that PLA is the most promising technology at present in technological terms, whereas PHAs, PCL, and PBS are uncertain technologies and PBAT has a rather low development potential.     

分光光度法测定五种补肾中成药中铝的含量

用分光光度法测定蚁王壮力胶囊,三五神威丸、颐和春、强力生血宝,海马二肾丸五种补肾中成药中铝的含量。结果表明,五种中成药中铝含量有显著差异。其中以三五神威丸中铝的含量最高。     

治疗冠心病中成药中镁含量的测定及其临床意义

采用原子吸收分光光度法测定了１１种治疗冠心病中成药物中镁含量。结果表明,药物中含有较丰富的镁元素,它为临床上探讨镁元素与冠心病关系提供了有用的数据。     

Nigella sativa L. and COVID-19: A Glance at The Anti-COVID-19 Chemical Constituents,Clinical Trials,Inventions, and Patent Literature

COVID-19 has had an impact on human quality of life and economics. Scientists have been identifying remedies for its prevention and treatment from all possible sources, including plants. Nigella sativa L. (NS) is an important medicinal plant of Islamic value. This review highlights the anti-COVID-19 potential, clinical trials, inventions, and patent literature related to NS and its major chemical constituents, like thymoquinone. The literature was collected from different databases, including Pubmed, Espacenet, and Patentscope. The literature supports the efficacy of NS, NS oil (NSO), and its chemical constituents against COVID-19. The clinical data imply that NS and NSO can prevent and treat COVID-19 patients with a faster recovery rate. Several inventions comprising NS and NSO have been claimed in patent applications to prevent/treat COVID-19. The patent literature cites NS as an immunomodulator, antioxidant, anti-inflammatory, a source of anti-SARS-CoV-2 compounds, and a plant having protective effects on the lungs. The available facts indicate that NS, NSO, and its various compositions have all the attributes to be used as a promising remedy to prevent, manage, and treat COVID-19 among high-risk people as well as for the therapy of COVID-19 patients of all age groups as a monotherapy or a combination therapy. Many compositions of NS in combination with countless medicinal herbs and medicines are still unexplored. Accordingly, the authors foresee a bright scope in developing NS-based anti-COVID-19 composition for clinical use in the future.     

2020年诺贝尔化学奖的再思考——归属争议与原创表彰

2020年诺贝尔化学奖授予两位女性科学家——埃马纽埃尔.卡彭蒂耶和詹妮弗.杜德纳。回顾CRISPR-Cas9技术的发展史,她们完整地说明了该技术的原理、作用,并研发了CRISPR-Cas9基因编辑技术,符合诺贝尔奖奖励原创的要求,是争议最小的获奖者人选。专利和诺贝尔奖在维护发明者权益、促进科学的发展上都具有重要的作用,且不能仅以其中一项的结果判断另一项的归属,目前的归属差异不影响非商业应用的学术研究,并客观上推动了原创研究的产出。进一步思考原创的概念,明确基础科学的定位,加强对创新人才的鼓励和支持,注重诺贝尔奖颁奖历史的梳理,也是本次诺贝尔奖给予我们的启示。     

中成药中马兜铃酸A的HPLC/MS分析方法

建立了中成药中马兜铃酸A的高效液相色谱/质谱检测方法.测定结果表明,马兜铃酸A的质谱有较强的分子离子峰,最低检测限为5 ng(信噪比等于10),可以满足对中成药中马兜铃酸A测定之要求.     

策略性授权与专利技术的拍卖许可

本文在双寡头垄断的市场中,考察了拍卖许可制度下企业所有者的策略性授权行为对技术专利持有者的最优许可政策的影响.结论表明,在一定条件下,对于价值较大的技术创新,策略性授权行为的存在会阻碍专利技术的扩散.最后给出政策含义.     

考虑专利保护和渠道偏好的再制造双渠道闭环供应链决策与协调

本文在电子商务环境下考虑消费者对零售渠道和直销渠道具有不同的渠道偏好,研究了专利许可零售商实施再制造的双渠道闭环供应链定价决策和协调问题。运用博弈论方法求得了集中决策和分散决策情形下的最优定价策略,并分析了消费者渠道偏好系数对节点企业最优定价策略及利润的影响。针对分散决策存在效率损失的问题,以集中决策的最优解为基准,通过联合运用一个由批发价格、直销价格和专利许可费构成的定价机制和一个利润分享机制,实现了双渠道闭环供应链的完美协调。     

兼顾功能与协调的企业专利质量评价研究——中国上市芯片企业的实证分析

现有研究缺乏一个较为合理完善的针对企业层面的专利质量评价方法,为科学、合理地评价企业专利质量,从专利技术质量、法律质量和经济质量三个维度建立了企业专利质量评价体系。基于主客观组合赋权法,进一步利用客观偏好系数融合两种聚合算子构建了兼顾功能与协调的企业专利质量组合赋权评价模型。并对2010年至2015年中国上市芯片企业专利质量进行实证研究,结果表明:该时期内芯片企业专利质量整体发展情况较为良好,但部分企业评价值存在较大起伏;一些芯片企业存在专利质量指标间“不协调”的问题,可能造成评价结果“虚高”,这在规模较小的企业中更为普遍;发明专利在芯片企业专利质量中具有重要地位。本文的研究可对企业提升专利质量以及政府制定专利政策提供实践借鉴。     

差异化竞争下考虑再制造专利许可的闭环供应链生产决策

针对高端产品和低端产品的差异化竞争,构建高端制造商将再制造专利许可作为外部竞争要素情形的闭环供应链竞合决策模型,研究消费者异质需求下再制造专利许可对闭环供应链生产决策、利润和环境效益的影响。研究结果表明:再制造专利许可是高端制造商的有效产品差异化竞争策略,可提高高端制造商利润,降低低端制造商利润;再制造专利许可策略对环境并不总是有利的,但消费者对再制造品的支付意愿越强,其环境效益越高。